Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus

Inflammatory Bowel Disease

The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases

Am J Gastroenterol.

Knox NC, Forbes JD, Peterson CL, Van Domselaar G, Bernstein CN

doi: 10.14309/ajg.0000000000000305.

REOMMENDED

Gastrointestinal Diseases

Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab

Dig Dis Sci.

Grandinetti T, Biedermann L, Bussmann C, Straumann A, Hruz P

doi: 10.1007/s10620-019-

Inflammatory Bowel Disease

Eosinophils in Inflammatory Bowel Disease

Inflamm Bowel Dis.

Filippone RT, Sahakian L, Apostolopoulos V, Nurgali K

doi: 10.1093/ibd/izz024.

Esophagus Diseases

Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study

Lancet Gastroenterol Hepatol.

Shoda T, Wen T, Aceves SS, Abonia JP, Atkins D, Bonis PA, Caldwell JM, Capocelli KE, Carpenter CL, Collins MH, Dellon ES, Eby MD, Gonsalves N, Gupta SK, Falk GW, Hirano I, Menard-Katcher P, Kuhl JT, Krischer JP, Leung J, Mukkada VA, Spergel JM, Trimarchi MP, Yang GY, Zimmermann N, Furuta GT, Rothenberg ME; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

doi: 10.1016/S2468-1253

The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort

Am J Gastroenterol.

Warners MJ, Oude Nijhuis RAB, de Wijkerslooth LRH, Smout AJPM, Bredenoord AJ

doi: 10.1038/

Inflammatory Bowel Disease

Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations

J Crohns Colitis.

Fu J, Wijmenga C, Zhernakova A, Dijkstra G, Festen EAM, Gacesa R, Vich Vila A, Weersma RK

doi: 10.1093/ecco-jcc/jjz077.

Inflammatory Bowel Disease

Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the disease

United European Gastroenterol J.

Schreiner P, Yilmaz B, Rossel JB, Franc Y, Misselwitz B, Scharl M, Zeitz J, Frei P, Greuter T, Vavricka SR, Pittet V, Siebenhüner A, Juillerat P, von Känel R, Macpherson AJ, Rogler G, Biedermann L, Swiss IBD Cohort Study Group.

doi: 10.1177/2050640619841249.

Inflammatory Bowel Disease

A pilot integrative analysis of colonic gene expression, gut microbiota and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways

J Crohns Colitis.

Quraishi MN, Acharjee A, Beggs AD, Horniblow R, Tselepis C, Gkoutus G, Ghosh S, Rossiter A, Loman N, van Schaik W, Withers D, Walters JRF, Hirschfield GM, Iqbal TH

doi: 10.1093/ecco-jcc/jjaa021.

Inflammatory Bowel Disease

Gut microbiota-driven drug metabolism in inflammatory bowel disease

J Crohns Colitis.

Crouwel F, Buiter HJC, de Boer NK

doi: 10.1093/ecco-jcc/jjaa143.

Related content

The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases

Eosinophilic Gastroenteritis: Clinical Manifestation, Natural Course, and Evaluation of Treatment with Corticosteroids and Vedolizumab

Eosinophils in Inflammatory Bowel Disease

Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study

The natural course of eosinophilic esophagitis and long-term consequences of undiagnosed disease in a large cohort

Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations

Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the disease

A pilot integrative analysis of colonic gene expression, gut microbiota and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways

Gut microbiota-driven drug metabolism in inflammatory bowel disease